P371
|
FEATURING ADIPOCYTES SECRETION AS PHARMACOLOGICAL TARGET FOR ADJUVANT IMMUNOTHERAPY AGAINST BREAST CANCER
|
Luis Henrique Correa1, LÍVIA PIMENTEL SANT’ANA DOURADO1, Kelly Grace Magalhaes1
|
1University of Brasilia, Brasilia, Brazil
|
Inflammation | Microbiome | Immune monitoring | Metabolism | Tumor infiltrating lymphocytes (TILs) | Immune suppression | Immune adjuvant | Tumor microenvironment
|